Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
- 1 March 2005
- Vol. 87 (3-4) , 287-297
- https://doi.org/10.1016/j.biochi.2005.01.014
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Matrix metalloproteinases in tumour invasion and metastasisThe Journal of Pathology, 1999
- Trendsin Molecular Medicine: Matrix metalloproteinases and their inhibitors in tumour growth and invasionAnnals of Medicine, 1999
- T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent MechanismThe American Journal of Pathology, 1999
- Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding ActivityCell, 1998
- Vascular Endothelial Growth Factor Increases Release of Gelatinase A and Decreases Release of Tissue Inhibitor of Metalloproteinases by Microvascular Endothelial Cellsin VitroMicrovascular Research, 1998
- Fibroblasts Stimulate Human Ovarian Cancer Cell Invasion and Expression of 72-kDa Gelatinase A (MMP-2)Gynecologic Oncology, 1997
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analysesBiochemical Journal, 1996
- Mechanism Of Cell Surface Activation Of 72-kDa Type IV CollagenaseJournal of Biological Chemistry, 1995